Healthcare Triangle Secures $1.63 Million Through Warrant Inducement Transaction

Healthcare Triangle, Inc. (Nasdaq: HCTI) has entered into warrant exercise agreements with three existing accredited investors to exercise outstanding warrants for aggregate gross proceeds of approximately $1.63 million. The transaction involves the immediate exercise of 812,775 existing warrants at a reduced exercise price of $2.00 per share, down from the original $20.92 per share, providing immediate capital infusion to the company.

In consideration for the immediate exercise of these warrants, the investors will receive new unregistered warrants to purchase up to an aggregate of 812,775 shares of common stock with an exercise price of $3.00 per share. These new warrants become exercisable upon stockholder approval and will expire five years from the date of such approval. The transaction represents a strategic financing move that provides immediate working capital while potentially generating additional future capital through the exercise of the new warrants.

The gross proceeds of approximately $1.63 million, excluding any potential future proceeds from the exercise of the new warrants and before deducting placement agent fees and other offering expenses, will support Healthcare Triangle's position as a leader in digital transformation solutions for healthcare and life sciences. The company specializes in helping healthcare organizations including hospitals, health systems, payers, and pharmaceutical companies improve health outcomes through better utilization of data and information technologies.

WallachBeth Capital is acting as sole placement agent for the warrant inducement transaction, which is expected to close on October 2, 2025, subject to customary closing conditions. This financing arrangement demonstrates investor confidence in Healthcare Triangle's business model and growth prospects within the highly regulated healthcare technology sector where the company has established expertise in cloud solutions, security and compliance, data lifecycle management, and healthcare interoperability.

The capital infusion comes at a time when healthcare organizations increasingly rely on digital transformation to address competitive threats and immediate business needs. Healthcare Triangle's achievement of HITRUST Certification for its Cloud and Data Platform, marketed as CloudEz™ and DataEz™, demonstrates the company's commitment to maintaining the highest standards for data protection and information security, which is particularly crucial in the sensitive healthcare and life sciences industries.